NCT00145704 · ADVERSE EVENTS

Adverse events

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density · Source last updated 2013-04-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame: May, 2002 to October 2008
Other-event reporting threshold: 5%

Participants affected / participants at risk, as reported
Safety group	Serious events	Other events	Deaths
Bisphosphonate and Growth Hormone Use bisphosphonate use and growth hormone use	0 / 3	0 / 3	Not reported / Not reported
Growth Hormone Only Growth hormone use only, no bisphosphonate used	0 / 3	0 / 3	Not reported / Not reported

Group identifiers: EG000: Bisphosphonate and Growth Hormone Use · EG001: Growth Hormone Only

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

Complete source fields

event Groups

description
bisphosphonate use and growth hormone use
id
EG000
other Num Affected
0
other Num At Risk
3
serious Num Affected
0
serious Num At Risk
3
title
Bisphosphonate and Growth Hormone Use
description
Growth hormone use only, no bisphosphonate used
id
EG001
other Num Affected
0
other Num At Risk
3
serious Num Affected
0
serious Num At Risk
3
title
Growth Hormone Only

frequency Threshold

time Frame

May, 2002 to October 2008

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice